Similar articles

• von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

  Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lämmle B. Furlan M, et al. N Engl J Med. 1998 Nov 26;339(22):1578-84. doi: 10.1056/NEJM199811263392202. N Engl J Med. 1998. PMID: 9828245
• Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).

  Gerritsen HE, Turecek PL, Schwarz HP, Lämmle B, Furlan M. Gerritsen HE, et al. Thromb Haemost. 1999 Nov;82(5):1386-9. Thromb Haemost. 1999. PMID: 10595623
• [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].

  Masset C, Dubois B, Rorive G. Masset C, et al. Rev Med Liege. 2002 Jan;57(1):33-9. Rev Med Liege. 2002. PMID: 11899496 French.
• Not known from ADAM(TS-13)--novel insights into the pathophysiology of thrombotic microangiopathies.

  Wolf G. Wolf G. Nephrol Dial Transplant. 2004 Jul;19(7):1687-93. doi: 10.1093/ndt/gfh268. Epub 2004 May 5. Nephrol Dial Transplant. 2004. PMID: 15128885 Review. No abstract available.
• The "cutting" edge: von Willebrand factor-cleaving protease activity in thrombotic microangiopathies.

  Haspel RL, Jarolím P. Haspel RL, et al. Transfus Apher Sci. 2005 Apr;32(2):177-84. doi: 10.1016/j.transci.2004.10.017. Transfus Apher Sci. 2005. PMID: 15784452 Review.